Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $35.4 Million - $38.7 Million
157,100 Added 377.64%
198,700 $46.4 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $44.4 Million - $47.2 Million
-190,400 Reduced 82.07%
41,600 $10.3 Million
Q4 2023

Feb 14, 2024

BUY
$232.24 - $267.23 $19.3 Million - $22.2 Million
83,100 Added 55.81%
232,000 $56.6 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $15.9 Million - $17.7 Million
66,800 Added 81.36%
148,900 $39.3 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $12.9 Million - $14.6 Million
56,200 Added 216.99%
82,100 $19.4 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $2.77 Million - $3.26 Million
-12,700 Reduced 32.9%
25,900 $5.67 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $1.97 Million - $10.2 Million
38,600 New
38,600 $7.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.